Current status on development of steroids as anticancer agents

Journal of Steroid Biochemistry and Molecular Biology

Volumn 137, Issue , 2013, Pages 242-270

  Gupta, Atul ^a   Sathish Kumar, B ^a   Negi, Arvind S ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

17 Hydroxysteroids dehydrogenase inhibitors; Antiestrogens; Aromatase inhibitors; Hormone dependent cancers; Steroid conjugates; Steroid sulfatase inhibitors

Indexed keywords

17 FLUORINE SUBSTITUTED ESTRATRIENE; 17ALPHA BENZYL E2 3 O SULFAMATE; 17BETA (N DIISOPROPYLCARBAMOYL)ESTRA 1,3,5(10) TRIENE 3 O SULFAMATE; 17BETA HYDROXY 4 ARYLTHIA 4 ANDROSTEN 3 ONE; 2 BROMOESTRONE; 2 CHOLROESTRONE; 2 DIFLUOROMETHYLESTRONE 3 SULFAMATE; 2 METHOXYBISSULFAMATE; 2 METHOXYESTRADIOL; 21 (4 DIETHYLAMINOMETHYL 2 METHOXYPHENOXY) 7ALPHA METHYL 19 NORPREGNA 1,3,5(10) TRIEN 3 OL; 6 ALKYNYLOXYANDROST, 1,4 DIEN 17 ONE DERIVATIVE; 6 METHYL BETA NORANDROSTENEDIONE; 6BETA HYDROXYSTIGMASTA 4 EN 3 ONE; 6BETA, 19 EPOXYANDROST 4 ENE 3, 17 DIONE; ANASTROZOLE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ATAMESTANE; ESTRADIOL; EXEMESTANE; FORMESTANE; GLYCYRRHETINIC ACID; HORMONE INHIBITOR; LETROZOLE; NOMEGESTROL; OXATHIAZINE; RU 3941; SR 16137; SR 16157; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; COLON CARCINOMA; DRUG CYTOTOXICITY; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; HORMONE SYNTHESIS; HUMAN; IC 50; NONHUMAN; OSTEOPOROSIS; OVARY CANCER; OVARY CARCINOMA; PROSTATE CARCINOMA; REVIEW; STEROIDOGENESIS; UTERUS CANCER;

17Β-HYDROXYSTEROIDS DEHYDROGENASE INHIBITORS; ANTIESTROGENS; AROMATASE INHIBITORS; HORMONE DEPENDENT CANCERS; STEROID CONJUGATES; STEROID SULFATASE INHIBITORS;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; HUMANS; STEROIDS;

EID: 84886727811     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.05.011     Document Type: Review

References (167)

1. P. Irigaray, and D. Belpomme Basic properties and molecular mechanisms of exogenous chemical carcinogens Carcinogenesis 31 2010 135 148
2. WHO Cancer: Factsheet No. 297, February 2012.
3. W.L. Miller, and R.J. Auchus The molecular biology, biochemistry and physiology of human steroidogenesis and its disorders Endocrine Reviews 32 2011 81 151
4. G.G. Chen, Q. Zeng, and G.M. Tse Estrogen and its receptors in cancer Medicinal Research Reviews 28 2008 954 974
5. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Nobel lecture, Physiology or Medicine Stockholm, December 1985 284 324
6. M.J. Reed, A. Purohit, L.W.L. Woo, S.P. Newman, and B.V.L. Potter Steroid sulfatase: molecular biology, regulation, and inhibition Endocrinology Reviews 26 2005 171 202
7. R. Hobkrik Steroid sulfation: current concepts Trends in Endocrinology Metabolism 4 1993 69 74
8. H.J. Ruder, D.L. Loriaux, and M.B. Lipsett Estrone sulfate: production rate and metabolism in man Journal of Clinical Investigation 51 1972 1020 1023
9. C.T. Noel, M.J. Reed, H.S. Jacobs, and V.H.T. James The plasma concentration of oestrone sulphate in post-menopausal women: lack of diurnal variation, effect of ovariectomy, age and weight Journal of Steroid Biochemistry and Molecular Biology 14 1981 1101 1105 (Pubitemid 12218469)
10. J.R. Pasqualini The selective estrogen enzyme modulators in breast cancer: a review Biochimica et Biophysica Acta 1654 2004 123 143 (Pubitemid 38681205)
11. T.R. Evans, M.G. Rowlands, M. Law, and R.C. Coombes Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma British Journal of Cancer 69 1994 555 561 (Pubitemid 24076479)
12. T. Utsumi, N. Yoshimura, S. Takenchi, M. Maruta, K. Maeda, and N. Harada Elevated steroid sulphatase expression in breast cancer Journal of Steroid Biochemistry and Molecular Biology 73 2000 141 145 (Pubitemid 30488094)
13. O. Abulafia, Y.C. Lee, A. Wagreich, K. Economos, E. Serur, and V.L. Nacharaju Sulfatase activity in normal and neoplastic endometrium Gynecologic and Obstetric Investigation 67 2009 57 60
14. J.M. Day, A. Purohit, H.J. Tutill, P.A. Foster, L.W. Woo, B.V. Potter, and M.J. Reed The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy Annals of New York Academy of Sciences 1155 2009 80 87
15. T. Suzuki, Y. Miki, Y. Nakamura, K. Ito, and H. Sasano Steroid sulfatase and estrogen sulfotransferase in human carcinomas Molecular and Cellular Endocrinology 340 2011 148 153
16. A. Billich, P. Nussbaumer, and P. Lehr Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors Journal of Steroid Biochemistry and Molecular Biology 73 2000 225 235
17. G. Chetrite, J. Paris, J. Botella, and J.R. Pasqualini Effect of nomegestrol acetate on estrone-sulfatase and 17β-hydroxysteroid dehydrogenase activities in human breast cancer cells Journal of Steroid Biochemistry and Molecular Biology 58 1996 525 531 (Pubitemid 126657498)
18. H. Ishida, T. Nakata, M. Suzuki, Y. Shiotsu, H. Tanaka, and N. Sato A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated estrogen dependent growth of breast cancer cells in-vitro and in animal models Breast Cancer Research and Treatment 106 2007 215 217
19. Y. Jinbo, Y. Inoue, Novel estradiol derivatives, PCT Int. Appl. WO 2000053620 (2000).
20. L.C. Ciobanu, R.P. Boivin, V. Luu, F. Labrie, and D. Poirier Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17α-benzyl(or 4′-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and C17α of estradiol Journal of Medicinal Chemistry 42 1999 2280 2286 (Pubitemid 29284249)
21. R.H. Peters, W.R. Chao, B. Sato, K. Shigeno, N.T. Zaveri, and M. Tanabe Steroidal oxathiazine inhibitors of estrone sulfatase Steroids 68 2003 97 110 (Pubitemid 35418307)
22. M.L. MacCarthy, P.A. Townsend, and A. Purohit Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells Cancer Research 60 2001 5441 5450
23. M. Wang, L. Xu, M. gao, K.D. Miller, G.W. Sledge, and Q.H. Zheng Synthesis of 2-[11C]methoxy-3,17β-OO-bis(sulfamoyl)estradiol as a new potential PET agent for imaging of steroid sulfatase (STS) in cancers Steroids 77 2012 864 870
24. F. Jourdan, M.P. Leese, W. Dohle, E. Ferrandis, S.P. Newman, S. Chander, A. Purohit, and B.V.L. Potter Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents Journal of Medicinal Chemistry 54 2011 4863 4879
25. M.P. Leese, F.L. Jourdan, K. Gaukroger, M.F. Mahon, S.P. Newman, P.A. Foster, C. Stengel, S. Regis-Lydi, E. Ferrandis, A.D. Fiore, G.D. Simone, C.T. Supuran, A. Purohit, M.J. Reed, and B.V.L. Potter Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents Journal of Medicinal Chemistry 51 2008 1295 1308 (Pubitemid 351480390)
26. J.E. Reed, L.W.L. Woo, J.J. Robinson, B. Leblond, M.P. Leese, A. Purohit, M.J. Reed, and B.V.L. Potter 2-Difluoromethyloestrone 3-O-sulfamate, a highly potent steroid sulphatase inhibitor Biochemical and Biophysical Research Communications 317 2004 196 275
27. M.P. Leese, B. Leblond, A. Smith, S.P. Newman, A. Di Fiore, and G. De Simone 3,17-Disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in-vitro and in-vivo anticancer activity Journal of Medicinal Chemistry 49 2006 7683 7696
28. L.C. Ciobanu, V. Luu, C. Martel, F. Labrie, and D. Poirier inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase Cancer Research 63 2003 6442 6446 (Pubitemid 37255194)
29. M.P. Leese, H.A.M. Hejaz, M.F. Mahon, S.P. Newman, A. Purohit, M.J. Reed, and B.V.L. Potter A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents Journal of Medicinal Chemistry 48 2005 5243 5256 (Pubitemid 41113911)
30. L.M. Rasmussen, N.T. Zaveri, J. Stenvang, R.H. Peters, and A.E. Lykkesfeldt A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer Breast Cancer Research and Treatment 106 2007 191 203 (Pubitemid 350045017)
31. M.R. Waterman Anticancer drug target pictured Nature 457 2009 159 160
32. S. Chumsri, T. Howes, T. Bao, G. Sabnis, and A. Brodie Aromatase, aromatase inhibitors and breast cancer Journal of Steroid Biochemistry and Molecular Biology 125 2011 13 22
33. D. Ghosh, J. Griswold, M. Erman, and W. Pangborn Structural basis for androgen specificity and oestrogen synthesis in human aromatase Nature 457 2009 219 223
34. A.M.H. Brodie, W.M. Garrett, J.R. Handrickson, C.H. Tsai-Morris, P.A. Marcotte, and C.H. Robinson Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo Steroids 38 1981 693 702 (Pubitemid 12148995)
35. D. Poirier New cancer drugs targeting the biosynthesis of estrogens and androgens Drug Development Research 69 2008 304 318
36. S. Steckebroeck, D.D. Heidrich, B.S. Wagner, V.H. Hans, J. Schramm, F. Bidlingmaier, and D. Klingmuller Characterisation of aromatase cytochrome 450 in human temporal lobe Journal of Clinical Endocrinology and Metabolism 84 1999 2795 2801 (Pubitemid 30642015)
37. P. Lombardi Exemestane, a new steroidal aromatase inhibitor of clinical relevance Biochimica et Biophysica Acta 1587 2002 326 337 (Pubitemid 34655801)
38. M.R. Yadav, P.M. Sabale, R. Giridhar, C. Zimmer, J. Haupenthal, and R.W. Hartmann Synthesis of some novel androstanes as potential aromatase inhibitors Steroids 76 2011 464 470
39. S. Komatsu, A. Yaguchi, K. Yamashita, M. Nagaoka, and M. Numazawa 6β,19-Bridged androstenedione analogs as aromatase inhibitors Steroids 74 2009 884 889
40. M. Numazawa, M. Ando, Y. Watari, T. Tominaga, Y. Hayata, and A. Yoshimura Journal of Steroid Biochemistry and Molecular Biology 96 2005 51 58
41. M.J. Balunas, B. Su, S. Riswan, H.H.S. Fong, R.W. Brueggemeier, J.M. Pezzuto, and A.D. Kinghorn Isolation and characterization of aromatase inhibitors from Brassaiopsis glomerulata (Araliaceae) Phytochemistry Letters 2 2009 29 33
42. M. Numazawa, and M. Oshibe Further studies on 6-alkylandrost-4-ene-3,17- diones as aromatase inhibitors: elongation of the 6-alkyl chain Steroids 60 1995 506 511
43. M.R. Yadav, P.M. Sabale, R. Giridhar, C. Zimmer, and R.W. Hartmann Steroidal carbonitriles as potential aromatase inhibitors Steroids 77 2012 850 857
44. M. Nagaoka, Y. Watari, H. Yajima, K. Tsukioka, Y. Muroi, K. Yamada, and M. Numazawa Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids Steroids 68 2003 533 542 (Pubitemid 36945408)
45. M.A.C. Neves, T.C.P. Dinis, G. Colombo, and M.L. SaeMelo An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors European Journal of Medical Chemistry 44 2009 4121 4127
46. M. Numazawa, W. Handa, C. Hasegawa, and M. Takahashi Structure-activity relationships of 2α-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions Journal of Steroid Biochemistry and Molecular Biology 97 2005 353 359 (Pubitemid 41619414)
47. D. Ghosh, J. Lo, D. Morton, D. Valette, J. Xi, J. Griswold, S. Hubbell, C. Egbuta, W. Jiang, J. An, and H.M.L. Davies Novel aromatase inhibitors by structure-guided design Journal of Medicinal Chemistry 55 2012 8464 8476
48. C. Varela, E.J.T. da Silva, C. Amaral, G.C. da Silva, T. Baptista, S. Alcaro, G. Costa, R.A. Carvalho, N.A.A. Teixeira, and F.M.F. Roleira New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation Journal of Medicinal Chemistry 55 2012 3992 4002
49. M. Oberwinkler, C. Henn, G. Moller, T. Klein, M. Negri, A. Oster, A. Spadaro, R. Werth, M. Wetzel, K. Xu, M. Frotscher, R.W. Hartmann, and J. Adamski 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development Journal of Steroid Biochemistry and Molecular Biology 125 2011 66 82
50. P. Vihko, P. Harkonen, O. Oduwole, S. Torn, R. Kurkela, K. Porvari, A. Pulkka, and V. Isomaa 17β-Hydroxysteroid dehydrogenase and cancers Journal of Steroid Biochemistry and Molecular Biology 83 2003 119 122
51. R. Mindnich, G. Moller, and J. Adamski The role of 17β- hydroxysteroid dehydrogenases Molecular and Cellular Endocrinology 218 2004 7 20
52. F. Labrie, V. Luu, S.X. Lin, J. Simard, C. Labrie, M. El-Alfy, G. Pelletier, and A. Belanger Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease Journal of Molecular Endocrinology 25 2000 1 16 (Pubitemid 30618058)
53. J. Fomitcheva, M.E. Baker, E. Anderson, G.Y. Lee, and N. Aziz Characterization of Ke 6, a new 17β-hydroxysteroid dehydrogenase, and its expression in gonadal tissues Journal of Biological Chemistry 273 1998 22664 22671 (Pubitemid 28399837)
54. V. Luu Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase Journal of Steroid Biochemistry and Molecular Biology 76 2001 143 151
55. S. Nagasaki, T. Suzuki, Y. Miki, J. Akira, K. Kitada, T. Ishida, H. Handa, N. Ohuchi, and H. Sasano 17β-Hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis Cancer Research 69 2009 1392 1399
56. K.K. Rasiah, M. Gardiner-Garden, E.J. Padilla, G. Moller, J.G. Kench, M.C. Alles, S.A. Eggleton, P.D. Stricker, J. Adamski, R.L. Sutherland, S.M. Henshall, and V.M. Hayes HSD17β4 over-expression, an independent biomarker of poor patient outcome in prostate cancer Molecular and Cellular Endocrinology 310 2009 89 96
57. M. Poutanen, V. Isomaa, V.P. Lehto, and R. Vihko Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue International Journal of Cancer 50 1992 386 390
58. P. Vihko, P. Harkonen, O. Oduwole, S. Torn, R. Kurkela, K. Porvari, A. Pulkka, and V. Isomaa 17β-Hydroxysteroid dehydrogenases and cancers Journal of Steroid Biochemistry and Molecular Biology 83 2002 119 122
59. T.E. Spires, B.E. Fink, E.K. Kick, and D. You Identification of novel functional inhibitors of 17β-hydroxysteroid dehydrogenase type-III (17β-HSD3) Prostate 65 2005 159 170 (Pubitemid 41362283)
60. D. Poirier, P. Dionne, and S. Auger a 6β-(thiaheptanamide) derivative of estradiol as inhibitor of 17β-hydroxysteroid dehydrogenase type 1 Journal of Steroid Biochemistry and Molecular Biology 64 1998 83 90 (Pubitemid 28132850)
61. C. Cadot, Y. Laplante, F. Kamal, V. Luu, and D. Poirier C6-(N,N-butyl-methyl-heptanamide) derivatives of estrone and estradiol as inhibitors of type 1 17β-hydroxysteroid dehydrogenase: chemical synthesis and biological evaluation Bioorganic and Medicinal Chemistry 15 2007 714 726 (Pubitemid 44880729)
62. D. Poirier, P. Bydal, M.R. Tremblay, K.M. Sam, and V. Luu Inhibitors of type II 17β-hydroxysteroid dehydrogenase Molecular and Cellular Endocrinology 171 2001 119 128
63. P. Bydal, S. Auger, and D. Poirier Inhibition of type 2 17β-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure-activity relationships Steroids 69 2004 325 342 (Pubitemid 38803000)
64. H. Lawrence, H. Vicker, N. Allan, G.M. Smith, A. Mahon, M. Tutill, H.J. Purohit, A. Reed, M.J. Reed, and B.V.L. Potter Novel and potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors Journal of Medicinal Chemistry 48 2005 2759 2762 (Pubitemid 40548090)
65. D. Poirier, R.P. Boivin, M.R. Tremblay, M. Berube, W. Qiu, and S.X. Lin Estradiol-adenosine hybrid compounds designed to inhibit type 1, 17β-hydroxysteroid dehydrogenase Journal of Medicinal Chemistry 48 2005 8134 8147 (Pubitemid 43032522)
66. M. Berube, and D. Poirier Synthesis of simplified hybrid inhibitors of type 1 17β-hydroxysteroid dehydrogenase via cross metathesis and sonogashira coupling reactions Organic Letters 6 2004 3127 3130 (Pubitemid 39233136)
67. B.T. Ngatcha, V. Luu, F. Labrie, and D. Poirier Androsterone 3α-ether-3β-substituted and androsterone 3α-substituted derivatives as inhibitors of type 3 17α-hydroxysteroid dehydrogenase: chemical synthesis and structure-activity relationship Journal of Medicinal Chemistry 48 2005 5257 5268 (Pubitemid 41113912)
68. B. Husen, K. Huhtinen, T. Saloniemi, J. Messinger, H.H. Thole, and M. Poutanen Human hydroxysteroids dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts Endocrinology 147 2006 5333 5339 (Pubitemid 44790588)
69. D. Deluka, G. Moller, A. Rosinus, W. Elger, A. Hillisch, and J. Adamski Inhibitory effects of fluorine-substituted estrogens on the activity of 17β-hydroxysteroid dehydrogenases Molecular and Cellular Endocrinology 248 2006 218 224
70. G.M. Allan, C. Bubert, N. Vicker, A. Smith, H.J. Tutill, A. Purohit, M.J. Reed, and B.V.L. Potter Novel, potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1 Molecular and Cellular Endocrinology 248 2006 204 207
71. D. Poirier, H.J. Chang, A. Azzi, R.P. Boivin, and S.X. Lin Estrone and estradiol C-16 derivatives as inhibitors of type 1 17β-hydroxysteroid dehydrogenase Molecular and Cellular Endocrinology 248 2006 236 238
72. F. Rouillard, J. Lefebvre, M.A. Fournier, and D. Poirier Chemical synthesis, 17β-hydroxysteroid dehydrogenase type 1 inhibitory activity and assessment in in-vitro and in-vivo estrogenic activities of estradiol derivatives The Open Enzyme Inhibition Journal 1 2008 61 71
73. M. Majumdar, D. Fournier, D.W. Zhu, C. Cadot, D. Poirier, and S.X. Lin Binary and ternary crystal structure of a novel inhibitor with 17β-HSD type 1: a lead compound for breast cancer therapy Biochemistry Journal 424 2009 357 366
74. P. Bydal, V. Luu, F. Labrie, and D. Poirier Steroidal lactones as inhibitors of 17β-hydroxysteroid dehydrogenase type5: chemical synthesis, enzyme inhibitory activity and assessment of estrogenic and androgenic activities European Journal of Medical Chemistry 44 2009 632 644
75. G. Moller, D. deluca, C. Gege, A. Rosinus, D. Kowalik, O. Peters, P. Droescher, W. Elger, J. Adamski, and A. Hillisch Structure-based design, synthesis and in vitro characterization of potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone Bioorganic and Medicinal Chemistry Letters 19 2009 6740 6744
76. S. Ray, and I. Dwivedy Development of estrogen antagonists as pharmaceutical agents Advances in Drug Research 29 1997 171 270 (Pubitemid 27368069)
77. A. Claussner, L. Nedelec, F. Nique, D. Philibert, G. Teutsch, and P. Van de Velde 11-β-Amidoalkyl estradiols, a new series of pure antiestrogens Journal of Steroid Biochemistry and Molecular Biology 41 1992 609 614
78. V. Agouridas, E. Magnier, J.C. Blazejewski, I. Laios, A. Cleeren, D. Nonclercq, G. Laurent, and G. Leclercq Effect of fluorination on the pharmacological profile of 11β-isomers of fulvestrant in breast carcinoma cells Journal of Medicinal Chemistry 52 2009 883 887
79. F. Nique, P. Van de Velde, J. Brémaud, M. Hardy, D. Philibert, and G. Teutsch 11β-Amidoalkoxyphenyl estradiols, a new series of pure antiestrogens Journal of Steroid Biochemistry and Molecular Biology 50 1994 21 29
80. A.E. Wakeling, and J. Bowler ICI 182,780, a new antiestrogen with clinical potential Journal of Steroid Biochemistry and Molecular Biology 43 1992 173 177
81. E.C. Svensson, E. Markstrom, R. Shao, M. Andersson, and H. Billig Progesterone receptor antagonists ORG 31710 and RU 486 increase apoptosis in human periovulatory granulosa cells Fertility and Sterility 76 2001 1225 1231 (Pubitemid 33116391)
82. Q. Xu, S. Takekida, N. Ohara, W. Chen, R. Sitruk-Ware, E.D. Johansson, and T. Maruo Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5′-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells Journal of Clinical Endocrinology and Metabolism 90 2005 953 961 (Pubitemid 40279221)
83. H.J. Kloosterboer, G.H. Deckers, W.G. Schoonen, R.G. Hanssen, U.M. Rose, P.M. Verbost, J.G. Hsiu, R.F. Williams, and G.D. Hodgen Preclinical experience with two selective progesterone receptor modulators on breast and endometrium Steroids 65 2000 733 740
84. R.D. Wiehle, K. Christov, and R. Mehta Anti-progestins suppress the growth of established tumors induced by 7,12-dimethylbenz(a)anthracene: comparison between RU486 and a new 21-substituted-19-nor-progestin Oncology Reports 18 2007 167 174
85. A.A. Goyeneche, E.E. Seidel, and C.M. Telleria Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2 Investigational New Drugs 30 2012 967 980
86. W. Afhuppe, J.M. Beekman, C. Otto, J. Hoffmann, U. Fuhrmann, and C. Moller In vitro characterization of ZK 230211 - a type III progesterone receptor antagonist with enhanced antiproliferative properties Journal of Steroid Biochemistry and Molecular Biology 119 2010 45 55
87. Y. Hayakawa, K. Furihata, K. Shin-ya, and T. Mori Gymnasterol, a new antitumor steroid against IGF-dependent cells from Gymnascella dankaliensis Tetrahedron Letters 44 2003 1165 1166 (Pubitemid 36144126)
88. X. Hea, B. Liuc, G. Wang, X. Wang, L. Sud, G. Qud, and X. Yao Microbial metabolism of methyl protodioscin by Aspergillus niger culture - a new androstenedione producing way from steroid Journal of Steroid Biochemistry and Molecular Biology 100 2006 87 94 (Pubitemid 44067456)
89. P.C. Kuo, T.H. Kuo, A.G. Damu, C.R. Su, E.J. Lee, T.S. Wu, R. Shu, C.M. Chen, K.F. Bastow, T.H. Chen, K.H. Lee, and A. Physanolide A novel skeleton steroid, and other cytotoxic principles from Physalis angulata Organic Letters 8 2006 2953 2956 (Pubitemid 44154403)
90. I. Kontiza, D. Abatis, K. Malakate, C. Vagias, and V. Roussis 3-Keto steroids from the marine organisms Dendrophyllia cornigera and Cymodocea nodosa Steroids 71 2006 177 181 (Pubitemid 43087743)
91. L. Misra, P. Lal, N.D. Chaurasia, R.S. Sangwan, S. Sinha, and R. Tuli Selective reactivity of 2-mercaptoethanol with 5β,6β-epoxide in steroids from Withania somnifera Steroids 73 2008 245 251 (Pubitemid 351181432)
92. A.K. Samadi, X. Tong, R. Mukerji, H. Zhang, B.N. Timmermann, and M.S. Cohen Withaferin A, a cytotoxic steroid from Vassobia breWiflora, induces apoptosis in human head and neck squamous cell carcinoma Journal of Natural Products 73 2010 1476 1481
93. S. Boonananwong, B. Kongkathip, and N. Kongkathip First synthesis of 3,16,20-polyoxygenated cholestanes, new cytotoxic steroids from the gorgonian Leptogorgia sarmentosa Steroids 73 2008 1123 1127
94. N.V. Ivanchina, A.A. Kicha, and V.A. Stonik Steroid glycosides from marine organisms Steroids 76 2011 425 454
95. J. MalIkova, J. Swaczynova, Z. Kolar, and M. Strnad Anticancer and antiproliferative activity of natural brassinosteroids Phytochemistry 69 2008 418 426
96. V.M. Dembitsky Bioactive peroxides as potential therapeutic agents European Journal of Medical Chemistry 43 2008 223 251 (Pubitemid 351215614)
97. S. Piacente, M. Masullo, N.D. Neve, J. Dewelle, A. Hamed, R. Kiss, and T. Mijatovic Cardenolides from Pergularia tomentosa display cytotoxic activity resulting from their potent inhibition of Na+/K+-ATPase Journal of Natural Products 72 2009 1087 1091
98. S.B. Wu, Y.P. Ji, J.-J. Zhu, Y. Zhao, G. Xia, Y.H. Hu, and J.F. Hu Steroids from the leaves of Chinese Melia azedarach and their cytotoxic effects on human cancer cell lines Steroids 74 2009 761 765
99. N. Huu Tung, C.V. Minh, T.T. Ha, P.V. Kiem, H.T. Huong, N.T. Dat, N.X. Nhiem, B.H. Tai, J.H. Hyun, H.K. Kang, and Y.H. Kim C29 sterols with a cyclopropane ring at C-25 and 26 from the Vietnamese marine sponge Ianthella sp. and their anticancer properties Bioorganic and Medicinal Chemistry Letters 19 2009 4584 4588
100. L.W. Qi, C.Z. Wang, and C.S. Yuan American ginseng: potential structure-function relationship in cancer chemoprevention Biochemical Pharmacology 80 2010 947 954
101. A.S. Lin, S. Engel, B.A. Smith, C.R. Fairchild, W. Aalbersberg, M.E. Hay, and J. Kubanek Structure and biological evaluation of novel cytotoxic sterol glycosides from the marine red alga Peyssonnelia sp Bioorganic and Medicinal Chemistry 18 2010 8264 8269
102. R. Gasper, T. Mijatovic, A. Bénard, A. Derenne, R. Kiss, and E. Goormaghtigh FTIR spectral signature of the effect of cardiotonic steroids with antitumoral properties on a prostate cancer cell line Biochimica et Biophysica Acta 1802 2010 1087 1094
103. Z.W. Xu, F.M. Wang, M.J. Gao, X.Y. Chen, N.N. Shan, S.X. Cheng, X. Mai, G.H. Zala, W.L. Hu, and R.C. Xu Cardiotonic steroids attenuate ERK phosphorylation and generate cell cycle arrest to block human hepatoma cell growth Journal of Steroid Biochemistry and Molecular Biology 125 2011 181 191
104. L.J. Rashan, K. Franke, M.M. Khine, G. Kelter, H.H. Fiebig, J. Neumann, and L.A. Wessjohann Characterization of the anticancer properties of monoglycosidic cardenolides isolated from Nerium oleander and Streptocaulon tomentosum Journal of Ethnopharmacology 134 2011 781 788
105. J. Steigerova, L. Rarova, J. Oklešt'kova, K. Krizova, M. Levkova, M. Švachova, Z. Kolar, and M. Strnad Mechanisms of natural brassinosteroid-induced apoptosis of prostate cancer cells Food and Chemical Toxicology 50 2012 4068 4076
106. Q.Y. Tong, Y. He, Q.B. Zhao, Y. Qing, W. Huang, and X.H. Wu Cytotoxicity and apoptosis-inducing effect of steroidal saponins from Dioscorea zingiberensis Wright against cancer cells Steroids 77 2012 1219 1227
107. M.J. Manase, A.C.M. Offer, D. Pertuit, T. Miyamoto, C. Tanaka, S. Delemasure, P. Dutartre, J.F. Mirjolet, O. Duchamp, and M.A.L. Dubois Solanum incanum and S. heteracanthum as sources of biologically active steroid glycosides: confirmation of their synonymy Fitoterapia 83 2012 1115 1119
108. K. Arpha, C. Phosri, N. Suwannasai, W. Mongkolthanaruk, and S. Sodngam Astraodoric acids A-D: new lanostane triterpenes from edible mushroom Astraeus odoratus and their anti-Mycobacterium tuberculosis H37Ra and cytotoxic activity Journal of Agricultural and Food Chemistry 60 2012 9834 9841
109. M. Cushman, H.M. He, J.A. Katzenellenbogen, R.K. Varma, E. Hamel, C.M. Lin, S. Ram, and Y.P. Sachdeva Synthesis of analogs of 2-methoxyestradiol with enhanced inhibitory effects on tubulin polymerization and cancer cell growth Journal of Medicinal Chemistry 40 1997 2323 2334 (Pubitemid 27342567)
110. M. Nakamura, Y. Katsuki, Y. Shibutani, and T. Oikawa Dienogest a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis European Journal of Pharmacology 386 1999 33 40 (Pubitemid 30009620)
111. Z. Wang, D. Yang, A.K. Mohanakrishnan, P.E. Fanwick, P. Nampoothiri, E. Hamel, and M. Cushman Synthesis of B-ring homologated estradiol analogues that modulate tubulin polymerization and microtubule stability Journal of Medicinal Chemistry 43 2000 2419 2429 (Pubitemid 30431941)
112. W. Xie, H. Peng, D. Kim, M. Kunkel, G. Powis, and L.H. Zalkow Structure activity relationship of Aza steroids as PI-PLC inhibitors Bioorganic and Medicinal Chemistry 9 2001 1073 1083 (Pubitemid 32453267)
113. D. Milic, T. Kop, Z. Juranic, M.J. Gasic, B. Tinant, G. Pocsfalvi, and B.A. Solaja Synthesis antiproliferative activity of A-ring aromatized and conduritol-like steroidal compounds Steroids 70 2005 922 932 (Pubitemid 41642652)
114. X. He, J. Tang, A. Qiao, G. Wang, M. Jiang, R.H. Liu, and X. Yao Cytotoxic biotransformed products from cinobufagin by Mucor spinosus and Aspergillus niger Steroids 71 2006 392 402 (Pubitemid 43675667)
115. G. Berube, D. Rabouin, V. Perron, B. N'Zemba, R.C. Gaudreault, S. Parent, and E. Asselin Synthesis of unique 17β-estradiol homo-dimers, estrogen receptors binding affinity evaluation and cytocidal activity on breast, intestinal and skin cancer cell lines Steroids 71 2006 911 921 (Pubitemid 44376405)
116. H.O. Saxena, U. Faridi, J.K. Kumar, S. Luqman, M.P. Darokar, K. Shanker, C.S. Chanotiya, M.M. Gupta, and A.S. Negi Synthesis of chalcone derivatives on steroidal framework and their anticancer activities Steroids 72 2007 892 900 (Pubitemid 47422269)
117. R. Bansal, and S. Guleria Synthesis of 16E-[3-methoxy-4-(2-aminoethoxy)- benzylidene]androstene derivatives as potent cytotoxic agents Steroids 73 2008 1391 1399
118. V.M.A. Moreira, T.S. Vasaitis, Z. Guo, V.C.O. Njar, and J.A.R. Salvador Synthesis of novel C17 steroidal carbamates Studies on CYP17 action, androgen receptor binding and function, and prostate cancer cell growth Steroids 73 2008 1217 1227
119. L.E. Kihel, M. Clément, M.A. Bazin, G. Descamps, M. Khalid, and S. Rault New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines Bioorganic and Medicinal Chemistry 16 2008 8737 8744
120. M.J. Kaskiw, M.L. Tassotto, M. Moka, S.L. Tokar, R. Pycko, J. Th'ng, and Z.H. Jiang Structural analogues of diosgenyl saponins: synthesis and anticancer activity Bioorganic and Medicinal Chemistry 17 2009 7670 7679
121. J. Roy, P. DeRoy, and D. Poirier 2β-(N-substituted piperazino)-5α-androstane-3α,17β-diols: parallel solid-phase synthesis and antiproliferative activity on human leukemia HL-60 cells Journal of Combinatorial Chemistry 9 2007 347 358
122. B. Slavikova, L. Kohout, M. Budesinsky, J. Swaczynova, A. Kasal, and Brassinosteroids Synthesis and activity of some fluoro analogues Journal of Medicinal Chemistry 51 2008 3979 3984 (Pubitemid 351956526)
123. A.Y. Misharina, A.R. Mehtieva, V.N. Zhabinskiib, V.A. Khripachb, V.P. Timofeevc, and Y.V. Tkachev Toxicity of (22R,23R)-22,23-dihydroxystigmastane derivatives to cultured cancer cells Steroids 75 2010 287 294
124. P. Bunyathaworn, S. Boonananwong, B. Kongkathip, and N. Kongkathip Further study on synthesis and evaluation of 3,16,20-polyoxygenated steroids of marine origin and their analogs as potent cytotoxic agents Steroids 75 2010 432 444
125. A.H. Banday, S.A. Shameem, B.D. Gupta, and H.M. Sampath Kumar D-ring substituted 1,2,3-triazolyl 20-keto pregnenanes as potential anticancer agents: synthesis and biological evaluation Steroids 75 2010 801 804
126. C. Li, W. Qiu, Z. Yang, J. Luo, F. Yang, M. Liu, J. Xie, and J. Tang Stereoselective synthesis of some methyl-substituted steroid hormones and their in vitro cytotoxic activity against human gastric cancer cell line MGC-803 Steroids 75 2010 859 869
127. H. Guo, G. Zhang, T. Zhang, X. He, Z. Wu, Y. Xiao, Y. Pan, G. Qiu, P. Liu, and X. Hu Synthesis, characterization and biological evaluation of some 16β-azolyl-3βamino-5α-androstane derivatives as potential anticancer agents European Journal of Medical Chemistry 46 2011 3662 3674
128. M.A. Fernández-Herrera, H. López-Muñoz, J.M.V. Hernández-Vázquez, M. López-Dávila, S. Mohan, M.L. Escobar-Sánchez, L. Sánchez-Sánchez, B.M. Pinto, and J. Sandoval-Ramírez Synthesis and biological evaluation of the glycoside (25R)-3β,16β-diacetoxy-22-oxocholest-5-en-26-yl β-d- glucopyranoside: a selective anticancer agent in cervicouterine cell lines European Journal of Medical Chemistry 46 2011 3877 3886
129. M.A. Fernández-Herrera, H. López-Muñoz, J.M.V. Hernández-Vázquez, M. López-Dávila, M.L. Escobar-Sánchez, L. Sánchez-Sánchez, B.M. Pinto, and J. Sandoval-Ramírez Synthesis of 26-hydroxy-22-oxocholestanic frameworks from diosgenin and hecogenin and their in vitro antiproliferative and apoptotic activity on human cervical cancer CaSki cells Bioorganic and Medicinal Chemistry 18 2010 2474 2484
130. M. Jensen, S. Schmidt, N.U. Fedosova, J. Mollenhauer, and H.H. Jensen Synthesis and evaluation of cardiac glycoside mimics as potential anticancer drugs Bioorganic and Medicinal Chemistry 19 2011 2407 2417
131. G.A. Elmegeed, W.K.B. Khalil, R.M. Mohareb, H.H. Ahmed, M.M. Abd-Elhalim, and G.H. Elsayed Cytotoxicity and gene expression profiles of novel synthesized steroid derivatives as chemotherapeutic anti-breast cancer agents Bioorganic and Medicinal Chemistry 19 2011 6860 6872
132. J.F.S. Carvalho, M.M.C. Silva, J.N. Moreira, S. Simoes, and M.L.S. Melo Sterols as anticancer agents: synthesis of ring-B oxygenated steroids, cytotoxic profile, and comprehensive SAR analysis Journal of Medicinal Chemistry 53 2010 7632 7638
133. A.H. Banday, B.P. Mir, I.H. Lone, K.A. Suri, and H.M.S. Kumar Studies on novel D-ring substituted steroidal pyrazolines as potential anticancer agents Steroids 75 2010 805 809
134. R. Minorics, T. Szekeres, G. Krupitza, P. Saiko, B. Giessrigl, J. Wölfling, E. Frank, and I. Zupko Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro Steroids 76 2011 156 162
135. 2Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: interaction with sex hormone binding globulin and anticancer activity Steroids 76 2011 393 399
136. H. Guo, H. Wu, J. Yang, Y. Xiao, H.J. Altenbach, G. Qiu, H. Hu, Z. Wu, X. He, D. Zhou, and X. Hu Synthesis, characterization and biological evaluation of some 16E-arylidene androstane derivatives as potential anticancer agents Steroids 76 2011 709 723
137. G. Panchapakesan, V. Dhayalan, N.D. Moorthy, N. Saranya, and A.K. Mohanakrishnan Synthesis of 2-substituted 17b-hydroxy/17-methylene estratrienes and their in vitro cytotoxicity in human cancer cell cultures Steroids 76 2011 1491 1504
138. S.K. Yousuf, R. Majeed, M. Ahmad, P.L. Sangwan, B. Purnima, A.K. Saxsena, K.A. Suri, D. Mukherjee, and S.C. Taneja Ring A structural modified derivatives of withaferin A and the evaluation of their cytotoxic potential Steroids 76 2011 1213 1222
139. M.I. Choudhary, M.S. Alam, A. Rahman, S. Yousuf, Y.C. Wu, A.S. Lin, and F. Shaheen Pregnenolone derivatives as potential anticancer agents Steroids 76 2011 1554 1559
140. D. Kovacs, Z. Kadar, G. Mótyán, G. Schneider, J. Wölfling, I. Zupkó, and É. Frank Synthesis, characterization and biological evaluation of some novel 17-isoxazoles in the estrone series Steroids 77 2012 1075 1085
141. R. Bansal, and P.C. Acharya Synthesis and antileukemic activity of 16E-[4-(2-carboxy)ethoxybenzylidene]-androstene amides Steroids 77 2012 552 557
142. Y. Li, J. Huang, J. Liu, P. Yan, H. Liu, Q. Sun, X. Wang, and C. Wang Synthesis and cytotoxicity of 17E-(2-aryl-2-oxo-1-ethylidene)-5a-androstane derivatives Steroids 76 2011 1615 1620
143. N.M. Krstic, M.S. Bjelakovic, V.D. Pavlovic, K. Robeyns, Z.D. Juranic, I. Matic, I. Novakovic, and D.M. Sladic New androst-4-en-17-spiro-1,3,2- oxathiaphospholanes. Synthesis, assignment of absolute configuration and in vitro cytotoxic and antimicrobial activities Steroids 77 2012 558 565
144. Z. Iványi, N. Szabo, J. Huber, J. Wolfling, I. Zupko, M. Szécsi, T. Wittmann, and G. Schneider Synthesis of D-ring-substituted (50R)- and (50S)-17b-pyrazolinylandrostene epimers and comparison of their potential anticancer activities Steroids 77 2012 566 574
145. L.H. Huang, Y.F. Zheng, Y.Z. Lu, C.J. Song, Y.G. Wang, B. Yu, and H.M. Liu Synthesis and biological evaluation of novel steroidal[17,16-d][1,2,4] triazolo [1,5-a]pyrimidines Steroids 77 2012 710 715
146. S. Parihar, A. Gupta, A.K. Chaturvedi, J. Agarwal, S. Luqman, B. Changkija, M. Manohar, D. Chanda, C.S. Chanotiya, K. Shanker, A. Dwivedi, R. Konwar, and A.S. Negi Gallic acid based steroidal phenstatin analogues for selective targeting of breast cancer cells through inhibiting tubulin polymerization Steroids 77 2012 878 886
147. H. Jegham, R. Maltais, P. Dufour, J. Roy, and D. Poirier Solid-phase chemical synthesis and in vitro biological evaluation of novel 2β-piperazino-(20R)-5α-pregnane-3α,20-diol N-derivatives as anti-leukemic agents Steroids 77 2012 1403 1418
148. L. Rarova, S. Zahler, J. Liebl, V. Krystof, D. Sedlak, P. Bartunek, L. Kohout, and M. Strnad Brassinosteroids inhibit in vitro angiogenesis in human endothelial cells Steroids 77 2012 1502 1509
149. R.M. Mohareb, and F. Al-Omran Reaction of pregnenolone with cyanoacetylhydrazine: novel synthesis of hydrazide-hydrazone, pyrazole, pyridine, thiazole, thiophene derivatives and their cytotoxicity evaluations Steroids 77 2012 1551 1559
150. G.G.L. Lanos, L.M. Araujo, I.A. Jiménez, L.M. Moujir, and I.L. Bazzocchi Withaferin A-related steroids from Withania aristata exhibit potent antiproliferative activity by inducing apoptosis in human tumor cells European Journal of Medical Chemistry 54 2012 499 511
151. H. Shamsuzzaman, A.M. Khanam, N. Dar, S. Siddiqui, and Rehman Synthesis, characterization, antimicrobial and anticancer studies of new steroidal pyrazolines Journal of Saudi Chemical Society 2012 10.1016/j.jscs.2012.05.004
152. T.F. Liu, X. Lu, H. Tang, M.M. Zhang, P. Wang, P. Sun, Z.Y. Liu, Z.L. Wang, L. Li, Y.C. Rui, T.J. Li, and W. Zhang 3β,5α,6β-Oxygenated sterols from the South China Sea gorgonian Muriceopsis flavida and their tumor cell growth inhibitory activity and apoptosis-inducing function Steroids 78 2013 108 114
153. A. Berenyi, R. Minorics, Z. Ivanyi, I. Ocsovszki, E. Ducza, H. Thole, J. Messinger, J. Wolfling, G. Motyan, E. Mernyak, E. Frank, G. Schneider, and I. Zupko Synthesis and investigation of the anticancer effects of estrone-16-oxime ethers in vitro Steroids 78 2013 69 78
154. J. Ren, Y. Wang, J. Wang, J. Lin, K. Wei, and R. Huang Synthesis and antitumor activity of N-sulfonyl-3,7-dioxo-5b-cholan-24-amides,ursodeoxycholic acid derivatives Steroids 78 2013 53 58
155. S. Parihar, A. Kumar, A.K. Chaturvedi, N.K. Sachan, S. Luqman, B. Changkija, M. Manohar, O. Prakash, D. Chanda, F. Khan, C.S. Chanotiya, K. Shanker, A. Dwivedi, R. Konwar, and A.S. Negi Synthesis of combretastatin A4 analogues on steroidal framework and their anti-breast cancer activity Journal of Steroid Biochemistry and Molecular Biology 105 2013 10.1016/j.jsbmb.2013.02. 009
156. E.J. Derbyshire, Y.C. Yang, G.A. Comin, J. Belloir, and P.E. Thorpe Heparin-steroid conjugates lacking glucocorticoids or mineralocorticoids activities inhibit the proliferation of vascular endothelial cells Biochimica et Biophysica Acta 1310 1996 86 96 (Pubitemid 26026221)
157. R. Devraj, J.F. Barrett, J.A. Fernandez, J.A. Katzenellenbogen, and M. Cushman Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates Journal of Medicinal Chemistry 39 1996 3367 3374 (Pubitemid 26322862)
158. C. Liu, J.S. Strobl, S. Bane, J.K. Schilling, M. McCracken, S.K. Chatterjee, R.R. Bata, and D.G.I. Kingston Design, synthesis, and bioactivities of steroid-linked taxol analogues as potential targeted drugs for prostate and breast cancer Journal of Natural Products 67 2004 152 159 (Pubitemid 38282901)
159. A. Gupta, P. Saha, C. Descoteaux, V. Leblanc, E. Asselin, and G. Berube Design, synthesis and biological evaluation of estradiol-chlorambucil hybrids as anticancer agents Bioorganic and Medicinal Chemistry Letters 20 2010 1614 1618
160. S. Adsule, S. Banerjee, F. Ahmed, S. Padhye, and F.H. Sarkar Hybrid anticancer agents: isothiocyanate-progesterone conjugates as chemotherapeutic agents and insights into their cytotoxicities Bioorganic and Medicinal Chemistry Letters 20 2010 1247 1251
161. L.H. Huang, Y.G. Wang, G. Xu, X.H. Zhang, Y.F. Zheng, H.L. He, W.Z. Fu, and H.M. Liu Novel 4-azasteroidal N-glycoside analogues bearing sugar-like D ring: synthesis and anticancer activities Bioorganic and Medicinal Chemistry Letters 21 2011 6203 6205
162. A. Kamal, M.K. Reddy, M.J. Ramaiah, R.J.S. Reddy, Y.V.V. Srikanth, D. Dasagiri, E.V. Bharthi, S.N.C.V.L. Pushpavalli, P. Sharma, and M. Pal-Bhadra Synthesis and Biological evaluation of estradiol linked pyrrolo [2,1-c]-[1,4]-benzodiazepine (PBD) conjugates as potential anticancer agents Bioorganic and Medicinal Chemistry 19 2011 2565 2581
163. J. Ruiz, V. Rodríguez, N. Cutillas, A. Espinosa, and M.J. Hannon A potent ruthenium(II) antitumor complex bearing a lipophilic levonorgestrel group Journal of Inorganic Chemistry 50 2011 9164 9171
164. P. Saha, C. Descôteaux, K. Brasseur, S. Fortin, V. Leblanc, S. Parent, E. Asselin, and G. Bérube Synthesis antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues European Journal of Medical Chemistry 48 2012 385 390
165. M.A. Fernandez-Herrera, H. Lopez-Munoz, J.M.V. Hernandez-Vazquez, L. Sanchez-Sanchez, M.L. Escobar-Sanchez, B.M. Pinto, and J. Sandoval-Ramirez Synthesis and selective anticancer activity of steroidal glycoconjugates European Journal of Medical Chemistry 54 2012 721 727
166. P. Saha, S. Fortin, V. Leblanc, S. Parent, E. Asselin, and G. Berube Design, synthesis, cytocidal activity and estrogen receptor a affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer Steroids 77 2012 1113 1122
167. K.L. Dao, and R.N. Hansen Targeting the estrogen receptor using steroid-therapeutic drug conjugates (hybrids) Bioconjugate Chemistry 23 2012 2129 2158